Vitamon K 0,145 mg or. sol. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vitamon k 0,145 mg or. sol. vial

omega pharma belgium sa-nv - phytomenadione 0,1523 mg/ml - oral solution - 0,145 mg - phytomenadione 145 µg/ml - phytomenadione

KONAKION MM PAEDIATRIC phytomenadione 2 mg/0.2 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

konakion mm paediatric phytomenadione 2 mg/0.2 ml injection ampoule

pharmaco australia ltd - phytomenadione, quantity: 10 mg/ml - injection, solution - excipient ingredients: glycocholic acid; lecithin; sodium hydroxide; hydrochloric acid; water for injections - prophylaxis and treatment of haemorrhagic disease of the newborn. indications as at 18 october 2000: prophylaxis and treatment of vitamin k deficiency bleeding (vkdb).

KONAKION MM phytomenadione 10 mg/1 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

konakion mm phytomenadione 10 mg/1 ml injection ampoule

pharmaco australia ltd - phytomenadione, quantity: 10 mg/ml - solution - excipient ingredients: hydrochloric acid; glycocholic acid; water for injections; lecithin; sodium hydroxide - haemorrhage or threatened haemorrhage as a result of severe "hypo-prothrombinaemia" (i.e. deficiency of coagulation factors ii, vii, ix and x) due, for instance, to overdosage of anticoagulants of the dicoumarol type, or to other forms of hypovitaminosis k (e.g. obstructive jaundice, liver and intestinal disorders or prolonged administration of antibiotics, sulfonamides or salicylates).